Date Closed

August 23, 2024

Lead Office

Montréal

Value

1.35 Billion CAD

On August 23, 2024, Quest Diagnostics completed its C$1.35 billion acquisition of LifeLabs from OMERS. Through this transaction, LifeLabs retains its brand, Canadian headquarters and management. Quest Diagnostics will provide LifeLabs with new expertise, innovations and resources, including improved online appointment scheduling and faster patient service centre processing.

Quest Diagnostics, based in Secaucus, New Jersey, provides diagnostic insights from the results of its laboratory testing to empower people, physicians and organizations to take action to improve health outcomes.

LifeLabs, headquartered in Toronto, Ontario, is Canada’s leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and healthcare practitioners to diagnose, treat, monitor and prevent disease. LifeLabs is a committed innovator in supporting Canadians to live healthier lives, operating Canada's first commercial genetics lab, and the country’s largest online patient portal, with more than 8 million Canadians receiving their results online.

McCarthy Tétrault advised Quest Diagnostics with a team led by Patrick M. Shea that included Aathmika Kularatnam, Meghan Noel, France Courtemanche (Corporate), Jason Gudofsky, Erin Keogh, Gideon Kwinter (Competition/Antitrust & Foreign Investment), Lisa Melanson, David Frost (Life Sciences), Karen Chow, Jeff Sun (Intellectual Property) Raj Juneja, Brendan Festeryga (Tax), Justine Lindner, Donovan Plomp, Jessica Hoskins, Lauren Soubolsky (Labour & Employment), Stephanie Sugar (Litigation), Kelleher Lynch, Julia Miller, Deron Waldock (Pensions, Benefits & Executive Compensation), Conrad Lee, Wendes Keung (Privacy), Laura Weingarden (Environment), Ted Cox, Niusha Arbabi, Madeleine Hawkins, Josiah Schaafsma, Izabela Kus, Anthony Salandra (Real Estate), Gajan Sathananthan (Trade) and Ian Mak, Iris Li, Ailbish Bruchet (Financial Services).